TScan Therapeutics (TCRX)
(Delayed Data from NSDQ)
$7.32 USD
+0.03 (0.41%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $7.30 -0.02 (-0.27%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth D Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.21 |
Last EPS Surprise | 30.00% |
ABR | 1.00 |
Earnings ESP
|
-6.58% |
---|---|
Current Year | -1.03 |
Next Year | -1.13 |
EPS (TTM) | -1.89 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 3.75M | 3.88M | 15.96M | 16.38M |
# of Estimates | 2 | 2 | 3 | 3 |
High Estimate | 5.00M | 5.25M | 21.55M | 21.98M |
Low Estimate | 2.50M | 2.50M | 10.00M | 10.00M |
Year ago Sales | 6.80M | 3.15M | 21.05M | 15.96M |
Year over Year Growth Est. | -44.85% | 23.02% | -24.16% | 2.61% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.25 | -1.03 | -1.13 |
# of Estimates | 3 | 2 | 4 | 3 |
Most Recent Consensus | -0.27 | -0.23 | -0.98 | -1.08 |
High Estimate | -0.24 | -0.23 | -0.98 | -1.08 |
Low Estimate | -0.27 | -0.26 | -1.08 | -1.17 |
Year ago EPS | -0.93 | -0.51 | -1.36 | -1.03 |
Year over Year Growth Est. | 73.12% | 50.98% | 24.26% | -9.95% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 1 | 1 | 0 |
Up Last 60 Days | 1 | 2 | 4 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 1 |
Down Last 60 Days | 1 | 0 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.25 | -1.03 | -1.13 |
7 Days Ago | -0.25 | -0.25 | -1.03 | -1.13 |
30 Days Ago | -0.25 | -0.26 | -1.04 | -1.09 |
60 Days Ago | -0.26 | -0.27 | -1.09 | -1.00 |
90 Days Ago | -0.26 | -0.27 | -1.09 | -1.00 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.27 | -0.23 | -0.98 | -1.08 |
Zacks Consensus Estimate | -0.25 | -0.25 | -1.03 | -1.13 |
Earnings ESP | -6.58% | 6.12% | 4.62% | 4.43% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.21 | -0.24 | -0.51 | -0.93 | NA |
Estimate | -0.30 | -0.43 | -0.76 | -0.73 | NA |
Difference | 0.09 | 0.19 | 0.25 | -0.20 | 0.08 |
Surprise | 30.00% | 44.19% | 32.89% | -27.40% | 19.92% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more